ETF Research
3 Ways To Play A Nearing Fed Rate Hike
With the target Fed Funds rate sitting at 0% for the last 6+ years, the Fed is finally getting poised to raise interest rates again. Many watchers felt a rate hike in 2015 was imminent […]
ETF Research
ETF Research
Investors Should Avoid This New Fund-Of-Funds ETF
I have a generally negative sentiment when it comes to “fund of funds” products whether they are mutual funds or ETFs. The main reason is that I think many of them layer on unnecessary fees […]
ETF Research
Wide Moat Investing: Is This ETF Delivering On Its Promise?
Wide moat investing – the idea of that a company can maintain a sustained competitive advantage – is a popular Warren Buffett endorsed strategy. The concept continues to gain steam as investors look for companies […]
ETF Research
3 ETFs That Are Being Killed By Their Expense Ratios
Mutual funds and ETFs have been a great way to provide loads of investing options to investors everywhere but if they have a drawback it can be how expenses and fees can eat into shareholder […]
ETF Research
Tuttle Tactical U.S. Core ETF Leads The Burgeoning ‘ETF Of ETFs’ Space
The concept of a “fund of funds” investment product has been around for some time. The most obvious example of this product is the target retirement date fund that almost every major investment management firm […]
ETF Research
This New ETF Looks To Take Advantage Of The Stock Buyback Trend
Companies, it seems, have had an insatiable appetite for buying back their own shares lately. It’s a strategy that is a bit of a double-edged sword. It’s great for shareholders as a reduced share count […]
ETF Research
Volatility Brings Buy-Write ETFs Into Focus
Market volatility as measured by the CBOE’s Volatility Index (VIX) has been on the rise thus far in 2015. Over the past couple of years, volatility has remained relatively tame as the market was marching […]
ETF Research
A New Biotech ETF Looks To Bring The Genomic Revolution To Investors
With biotechnology continuing to be the hot sector heading into 2015, we’ve seen several investment firms looking to capitalize on the trend. I’ve profiled a pair of those new biotech ETFs launched just recently here […]
ETF Research
A New Biotech ETF Targets Companies In Late Stage Clinical Trials
ETF providers seem eager to take advantage of the popularity of biotechs recently. The biotech sector as measured by the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) was up 34% in 2014 and has seen its assets […]
ETF Research
Yorkville High Income MLP ETF: A 13% Yield That Comes With Risks
Investors should be well aware of the dangers that come with chasing yields. In a vacuum, a dividend yield may look fantastic but a look under the sheets can reveal a great deal of ugliness. […]